In support of this, combined inhibition of EGF-R and IGF-1R by Gefitinib (Iressa) and AG1024, respectively, resulted in additive to synergistic inhibition of growth and induction of apoptosis in breast cancer cell lines (Camirand et al. 2005). The gene discussed is IGF1R; the disease is breast carcinoma.